Page last updated: 2024-10-25

ciprofloxacin and Congenital Myotonic Dystrophy

ciprofloxacin has been researched along with Congenital Myotonic Dystrophy in 2 studies

Ciprofloxacin: A broad-spectrum antimicrobial carboxyfluoroquinoline.
ciprofloxacin : A quinolone that is quinolin-4(1H)-one bearing cyclopropyl, carboxylic acid, fluoro and piperazin-1-yl substituents at positions 1, 3, 6 and 7, respectively.

Research Excerpts

ExcerptRelevanceReference
"Ciprofloxacin was the most common antibiotic used for treatment, and 70% of patients reported a good response to the initial course of treatment."1.36Bacterial overgrowth syndrome in myotonic muscular dystrophy is potentially treatable. ( Armstrong, D; James, C; Matteliano, A; Pearce, E; Tarnopolsky, MA, 2010)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Usluca, S1
Aksoy, U1
Tarnopolsky, MA1
Pearce, E1
Matteliano, A1
James, C1
Armstrong, D1

Other Studies

2 other studies available for ciprofloxacin and Congenital Myotonic Dystrophy

ArticleYear
[Microsporidium spp. infection in an immunocompromised child diagnosed by polymerase chain reaction].
    Mikrobiyoloji bulteni, 2010, Volume: 44, Issue:4

    Topics: Albendazole; Anti-Infective Agents; Child, Preschool; Ciprofloxacin; Diarrhea; Drug Therapy, Combina

2010
Bacterial overgrowth syndrome in myotonic muscular dystrophy is potentially treatable.
    Muscle & nerve, 2010, Volume: 42, Issue:6

    Topics: Adult; Anti-Infective Agents; Blind Loop Syndrome; Breath Tests; Ciprofloxacin; Female; Humans; Inte

2010